Researchers Evaluate Use of Contrast-Enhanced Ultrasonography for Gut GVHD Diagnosis, Monitoring

Contrast-enhanced ultrasonography can be a “feasible and helpful tool” to monitor graft-versus-host-disease (GVHD) of the gut, according to a new study.

Alina Daniela Tanase, MD, PhD, of the Fundeni Clinical Institute, and the Carol Davila University of Medicine and Pharmacy in Romania, and colleagues conducted the study and presented their findings during the 2024 Tandem Transplant & Cellular Therapy Meetings of ASTCT and CIBMTR.


Latest News

Our Contributors

Expert Interviews

Conference Highlights

Cecilia BrownConferences | February 28, 2024
New adverse drug reactions appeared in the updated labels of 94% of the agents evaluated.
Read More
Cecilia BrownConferences | February 27, 2024
New research highlights the importance of monitoring for interactions between oral anticancer drugs and other therapies.
Mary Mansour Riwes, DOConferences | February 27, 2024
Mary Mansour Riwes, DO, explains what she saw as the important news in GVHD at the 2024 Tandem Meetings.
Cecilia BrownConferences | February 27, 2024
Researchers used a deep learning software to measure muscle, fat, subcutaneous fat, and visceral fat in 3D scans.

Network Websites